BioCentury | Sep 16, 2013
Company News
Pertinax, MicroConstants China deal
...will fund development of the stromal cell-derived factor-1 ( SDF-1 ) analog in the country. Pertinax...
...the product, which is in Phase II testing. The companies declined to provide financial details. Pertinax Therapeutics Inc....
...the product, which is in Phase II testing. The companies declined to provide financial details. Pertinax Therapeutics Inc....